Company page

Medivir Ab

Medivir Ab is a public company listed on the Swedish market under the ticker MVIR, with a market capitalization of approximately 118.8 million SEK. The company is focused on developing innovative treatments in the field of infectious diseases. Medivir's research and development efforts aim to address unmet medical needs and improve patient outcomes.